Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis

Biomark Med. 2020 Jun;14(9):713-716. doi: 10.2217/bmm-2020-0201. Epub 2020 May 19.

Nicola Ielapi^{1

2}, Noemi Licastro^{1

3}, Michele Provenzano^{1

4}, Michele Andreucci^{1

4}, Stefano de Franciscis^{1

3}, Raffaele Serra^{1

3}

¹ Interuniversity Center of Phlebolymphology (CIFL), International Research & Educational Program in Clinical & Experimental Biotechnology at the Department of Medical & Surgical Sciences University Magna Graecia of Catanzaro, Viale Europa, Catanzaro 88100, Italy.
² Sapienza University of Rome, Department of Public Health & Infectious Disease, Roma, Italy.
³ Department of Medical & Surgical Sciences, University Magna Graecia of Catanzaro, Viale Europa, Catanzaro 88100, Italy.
⁴ Department of Health Sciences, University Magna Graecia of Catanzaro, Viale Europa, Catanzaro 88100, Italy.

No abstract available

Keywords: 2019-nCov; COVID-19; cardiovascular disease; heart; infection; vascular.

Publication types